Which investor invests in what?

European venture capital firm providing smart financial investment to innovative companies addressing global challenges and sustainable prosperity.

Kind

Venture capital

Stages

Series A · Series B · Series C+

Countries

Any country

Key fact

Typical round €19M

Last verified

Verified 10 Nov 2026

Kinnevik is a Swedish growth investment firm providing patient capital to technology-enabled businesses across Europe and the US, focusing on healthcare, software, and climate.

Kind

Venture capital

Stages

Series A · Series B · Series C+

Countries

EU-wide, US

Key fact

Typical round €89.6M

Last verified

Verified 10 Nov 2026

Insight Partners is a global venture capital and private equity firm investing across early to late-stage software, SaaS, and technology companies.

Kind

Venture capital

Stages

Series A · Series B · Series C+

Countries

Any country

Key fact

Typical round €61.4M

Last verified

Verified 10 Nov 2026

Thesis-driven European venture capital firm investing in early-stage startups building in the applied AI layer.

Kind

Venture capital

Stages

Seed · Series A · Series C+

Countries

Any country

Key fact

Ticket €1M–€10M

Last verified

Verified 10 Nov 2026

Munich-based venture capital firm investing primarily across Europe in life sciences and deep tech startups, backed by retail private investors.

Kind

Venture capital

Stages

Series A

Countries

Any country

Last verified

Verified 10 Nov 2026

Intel Capital is the corporate venture capital arm of Intel, investing globally in early-stage startups across emerging AI, deep tech, cloud, devices, and silicon.

Kind

Corporate venture capital

Stages

Series B · Series C+

Countries

Any country

Key fact

Typical round €159.4M

Last verified

Verified 10 Nov 2026

Venture capital firm investing in mission-driven founders tackling global challenges across transportation, healthcare, and digital infrastructure to reduce carbon emissions.

Kind

Venture capital

Stages

Seed · Series A · Series B

Countries

Any country

Key fact

Typical round €17.8M

Last verified

Verified 10 Nov 2026

Life sciences venture capital firm investing in and creating disruptive biotechnology companies across Europe and the United States.

Kind

Venture capital

Stages

Series C+

Countries

Any country

Last verified

Verified 10 Nov 2026

US life science venture capital firm investing in early-stage biotech and therapeutics, with a focus on oncology, neurology, and immunology.

Kind

Venture capital

Stages

Seed · Series A

Countries

Any country

Last verified

Verified 10 Nov 2026

European healthcare and biotech venture capital firm that builds spin-offs with academic research institutions and invests in early-stage medical device and biopharma companies.

Kind

Venture capital

Stages

Pre-seed · Seed · Series A · Series C+

Countries

Any country

Key fact

Typical round €45M

Last verified

Verified 10 Nov 2026

Seroba Lifesciences is a European venture capital firm investing in innovative biotech and medtech companies.

Kind

Venture capital

Countries

Any country

Last verified

Verified 10 Nov 2026

Cogito Capital Partners

Cogito Capital is an early-growth venture capital firm backing European technology companies with validated business models, strong market traction, and global expansion potential.

Kind

Venture capital

Stages

Series B

Countries

EU-wide

Last verified

Verified 10 Nov 2026

Belgian venture capital firm co-creating and investing in early- to mid-stage European life sciences companies focused on therapeutics, drug discovery, and drug development.

Kind

Venture capital

Stages

Series C+

Countries

Any country

Last verified

Verified 10 Nov 2026

UK venture capital firm investing from seed stage onwards into university deep-science spinouts across life sciences, deep tech, and physical sciences.

Kind

Venture capital

Stages

Seed · Series C+

Countries

Any country

Last verified

Verified 10 Nov 2026

Global venture capital firm backing enterprise AI companies that have reached product-market fit to help them scale go-to-market and operations.

Kind

Venture capital

Stages

Series C+

Countries

Any country

Key fact

Typical round €44.8M

Last verified

Verified 10 Nov 2026

INKEF Capital

Inkef is an early-stage venture capital investor partnering with startups to provide hands-on support and long-term strategic growth.

Kind

Venture capital

Stages

Pre-seed · Seed

Countries

Any country

Last verified

Verified 10 Nov 2026

Growth venture capital firm backing category leaders across AI infrastructure, quantum computing, physical AI, space, health, security, and sensing.

Kind

Venture capital

Stages

Series B · Series C+

Countries

Any country

Key fact

Typical round €235.8M

Last verified

Verified 10 Nov 2026

Ascenta Capital is a venture capital firm investing $15–30M in biotech companies advancing clinical drug development through Phase 1 and 2 as well as multi-medicine platforms.

Kind

Venture capital

Stages

Series C+

Countries

Any country

Key fact

Ticket €15M–€30M

Last verified

Verified 10 Nov 2026

Mundi Ventures is a European venture capital firm backing technology companies across Series A and growth stages, focusing on deep tech, AI, and sustainability.

Kind

Venture capital

Stages

Series A · Series B · Series C+

Countries

Any country

Last verified

Verified 10 Nov 2026

Early-stage European venture capital firm backing founders across multiple tech sectors, with an emphasis on seed-stage investments.

Kind

Venture capital

Stages

Seed · Series A · Series B

Countries

EU-wide

Key fact

Typical round €32.6M

Last verified

Verified 10 Nov 2026